Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation
NCT ID: NCT06188273
Last Updated: 2024-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
800 participants
OBSERVATIONAL
2024-01-01
2029-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Utilization of MAsS in Patients Undergoing LT for HCC
NCT05184283
Adverse Outcomes and Mortality in Liver Transplant
NCT05477277
Rapid Assessment of Donor Liver Quality
NCT03647059
The Clinical Study Aims to Assess the Quality of Donor Livers Using Hyperspectral Imaging.
NCT06608667
Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome
NCT03584204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myosteatotic Group
The group of patients was diagnosed with myosteatosis through CT imaging assessment before transplantation.
No interventions assigned to this group
Non-myosteatotic Group
The group of patients was diagnosed without myosteatosis through CT imaging assessment before transplantation.
No interventions assigned to this group
The Group with Severe Muscle Loss
The group of patients, through the comparison of CT images before and after transplantation, was diagnosed with significant muscle loss.
No interventions assigned to this group
The Group without Severe Muscle Loss
The group of patients, through the comparison of CT images before and after transplantation, was diagnosed without significant muscle loss.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Presence of portal vein tumor thrombus according to imageing before transplantation
* Presence of macrovascular invasion according to imageing before transplantation
* Re-transplants
* Multi-organ transplants
* Patients who died within 30 days after transplantation
* Patients diagnosed with skeletal muscle diseases (e.g. muscle atrophy)
* Patients with serious medical conditions such as heart failure, persistent infection, and renal insufficiency.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital of Zhejiang University
OTHER
Shulan (Hangzhou) Hospital
OTHER
The Affiliated Hospital of Qingdao University
OTHER
West China Hospital
OTHER
Huashan Hospital
OTHER
Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiao Xu
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CT2023-ZJU-OBS3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.